{
  "docId": "019de075-6f10-729e-9a0e-7ba50d16c411",
  "docSlug": "1d34cb0a1ad8b6cbf618b3c651d5261d",
  "documentTitle": "AbCellera | Results Presentation Deck | 14 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "deck",
  "documentKindLabel": "Deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 14,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a funnel-like diagram to illustrate the transition from discovery programs to clinical therapeutic antibodies.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-6f10-729e-9a0e-7ba50d16c411/4",
  "deckHref": "/decks/019de075-6f10-729e-9a0e-7ba50d16c411",
  "deckJsonHref": "/decks/019de075-6f10-729e-9a0e-7ba50d16c411.json",
  "deckAnchorHref": "/decks/019de075-6f10-729e-9a0e-7ba50d16c411#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.38,
        "x": 0.23,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Funnel diagram showing Programs Per Year narrowing down to Therapeutic Antibodies in the Clinic.",
      "attrs": null,
      "subkind": "funnel",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "81a9446e-319e-4808-b422-ba0cfa1d9fa3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.73,
        "y": 0.38
      },
      "kind": "metric",
      "text": "~$6B",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16b9378c-002f-49a0-bc80-6168d157ef23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.79,
        "y": 0.75
      },
      "kind": "metric",
      "text": "~$400B",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da9b028e-58dd-4759-922f-c670f94a6e31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.76,
        "y": 0.35
      },
      "kind": "source-note",
      "text": "Source: Allied Market Research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "326de96a-da30-47a2-a0a0-da94c7b8770f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.1,
        "x": 0.76,
        "y": 0.72
      },
      "kind": "source-note",
      "text": "Source: IQVIA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb4a5fa1-4f54-4bff-8efe-49ce330cea17",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.104,
        "y": 0.06
      },
      "kind": "title",
      "text": "MARKET OPPORTUNITY.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a00cc4dd-dbd8-456a-9fe3-04423749795a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.104,
        "y": 0.125
      },
      "kind": "title",
      "text": "AbCellera's end market is antibody medicines.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b09ea7ff-2368-4c7d-9319-e440f9757e56",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "7765f54e-1677-4264-8ea9-684d180b23c2",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Desire",
      "beatSlug": "aida-desire",
      "evidence": "market sizing and funding",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "7502d499-cd0f-4d39-bbf4-e543ea4acfc1",
      "evidence": "government funding drives value",
      "position": 0,
      "objective": "why AbCellera's business matters",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d3395928-51c9-47ae-884e-97f6409b30f3",
      "evidence": "~$220M in non-dilutive funding",
      "position": 1,
      "objective": "importance of funding",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}